Nevertheless, both methods of estimation (% inhibition and ratios correlated with control) indicate that both triazolo[3,4-b]thiadiazole derivatives exhibited significant inhibitory activity against Akt1and Akt2 phosphorylation in all three cancer cell lines. This evidence concerns the gene AKT2 and cancer.